Instrument Inactif

Communiqués Scythian Biosciences Corp Canadian Securities Exchange

Actions

CA7840531007

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

SOL Global Provides Interim Unaudited Financials for the First Quarter Ended February 2024	29/04	NE
SOL Global Announces Financial Results for Fiscal 2023	29/03	NE
SOL Global Announces Update on Portfolio Companies	26/01	NE
SOL Global Investments : 2023 Q3 Management’s Discussion & Analysis	27/10/23	PU
SOL Global Announces Third Quarter 2023 Financial Results	26/10/23	NE
SOL Global Announces Portfolio Company Damon Motors Entered into Business Combination to List on Nasdaq	24/10/23	NE
SOL Global Investments : 2023 Q2 Financial Statement	26/07/23	PU
SOL Global Investments : 2023 Q2 Management’s Discussion & Analysis	26/07/23	PU
SOL Global Investments : 2023 Q1 Management’s Discussion & Analysis	04/05/23	PU
SOL Global Investments : 2023 Q1 Financial Statement	04/05/23	PU
SOL Global Investments : ANNOUNCES MANAGEMENT CEASE TRADE ORDER	04/05/23	PU
SOL Global Investments : ANNOUNCES DELAY IN FILING AUDITED ANNUAL FINANCIAL STATEMENTS	04/05/23	PU
SOL Global Provides Interim Unaudited Financials for the Third Quarter Ended August 31, 2022	31/10/22	BU
SOL GLOBAL ISSUES SHARES TO REDUCE INDEBTEDNESS	21/09/22	AQ
SOL Global Continues Principal Re-payments towards $50 Million Credit Facility	05/09/22	AQ
SOL Global Continues Principal Re-payments Towards $50 Million Credit Facility	02/09/22	BU
SOL GLOBAL CONTINUES PRINCIPAL RE-PAYMENTS TOWARDS $50 MILLION CREDIT FACILITY	17/08/22	AQ
SOL Global Provides Interim Unaudited Financials for the Second Quarter Ended May 2022	29/07/22	BU
SOL Global Continues Principal Re-Payments Towards $50 Million Credit Facility	20/07/22	BU
SOL Global Closes $10 Million Loan Facility and Reduces Outstanding Principal on Existing Credit Facility	07/06/22	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Scythian Biosciences Corp Canadian Securities Exchange

Actions

CA7840531007

Communiqués

Filtres